President Trump Drops 10B IRS Lawsuit as DOJ Creates 18B Lawfare Compensation Fund EON Resources Inc Set to Present at Planet MicroCap Las Vegas 2026 Pentagon UFO Files Release Potential Implications for Defense and Aerospace Sectors Chinas Big Three Airlines Face Steep Challenges Amid Jet Fuel Costs and Rail Competition Unretirement Wave Why More Older Americans Are Rejoining the Workforce Japans Megabanks Report Record Profits Amid Caution Over Slowing Growth and Rising Risks APYX Q1 2026 Earnings EPS Beat Masks Revenue Uncertainty Shares Slip ACMR Q1 2026 Earnings Strong EPS Beat Drives Stock Higher SSSSL Q1 2026 Earnings Massive EPS Surprise Driven by Investment Gains NEWTI Q1 2026 Earnings EPS Misses Estimates Revenue Not Disclosed FFIV Q1 2026 Earnings EPS Surges Past Estimates as Software Growth Drives Profitability FULTP Q1 2026 Earnings Preferred Dividend Beat Supports Stable Income Profile NewAmsterdam Pharma Warrant NAMSW Faces Sharp Decline Testing Key Support Fortive FTV Shows Modest Decline Amid Consolidation Range Linde LIN Slips 12 as Defensive Positioning Wavers Key Support in Focus Novartis NVS Holds Gains Near 151 as Pharmaceutical Sector Shows Stability Auburn National Bancorporation AUBN Gains 122 as Shares Test Resistance Near 26 Fed Minutes Reveal Potential Rate Hikes as Iran War Risks Keep Inflation Elevated VSEC Q1 2026 Earnings EPS Surges Past Estimates Stock Dips Despite Strong Beat Sutro Biopharma STRO Surges 6 Key Levels and Market Dynamics Legato Merger Corp III LEGT Q1 2026 Earnings Positive EPS on Trust Earnings Amid Continued Search for Merger Target QuidelOrtho Q1 2026 Earnings EPS Misses Estimates by Wide Margin Yet Stock Rises Skye Bioscience Q1 2026 Earnings Wider Loss Than Expected as DevelopmentStage Biotech Continues Cash Burn EVEX Q1 2026 Earnings PreRevenue eVTOL Developer Reports WiderThanExpected Loss Amid Development Progress NCTY Q1 2012 Earnings Narrower Loss Than Expected as Revenue Picture Remains Unclear Rhinebeck Bancorp Inc RBKB Q1 2026 Earnings Modest Profitability Amid Quiet Quarter EVAX Q1 2026 Earnings WiderthanExpected Loss as Biotech Continues Development